Overview
|
What is Triall
Triall is laying the groundwork for tomorrow’s digital playing field in clinical trials. We bring Web 3.0 to medical research by developing a digital ecosystem of blockchain-integrated software solutions. Our blockchain infrastructure makes medical data tamper-resistant. It also enables secure and efficient connections between the many isolated systems and parties involved in clinical research. Our mission is to accelerate the introduction of safe and affordable vaccines and therapeutics into society by streamlining clinical trials. We bring Web 3.0 to medical research, by realizing a digital ecosystem for clinical trials. What are the unique benefits of the Triall ecosystem?- System Integration & Interoperability
- Efficiency & Operational Excellence
- Data integrity & Auditability
- Availability & Ease of Use
DetailsIDO (Prostarter Launchpad): Sep 28, 2021 - Sep 28, 2021IDO (TrustPad Launchpad): Sep 28, 2021 - Sep 28, 2021 Token supply: 175,000,000 TRL Total tokens for sale: 18,250,000 TRL Hard cap: 2,993,750 USD LegalBlockchain Platform: EthereumRegistration country: Netherlands Registration year: 2018 Office address: Bisonspoor 3002 – C701 (Copenhagen Tower), 3605 LT Maarssen, The Netherlands | Token infoTicker: TRLType: Utility-token Token standard: ERC20 Token price in USD: 1 TRL = 0,2 USD Accepted currencies: USDT Funds allocation: Liquidity, long-term operations & development - 8% 18% - Pre-sale 24% - Treasury 10% - Triall Community Fund 12,5% - Existing investors 8% - Advisors 10% - Founding team 9,5% - Growth, acquisition & marketing |
Project team

Hadil Es-Sbai, MSc
President | CEO

Niels Klomp, MSc
CTO

Dr. Linda van de Burgwal
CFO

Rob Posthumus, LL.M.
General Counsel

Raymond van der Waal, MSc
Head of Marketing

Dr. Joost Flach
Head of Clinical Affairs

Mark van der Waal, MSc
Head of Product
Advisors

Sina Djali
Head of Integrated Data Analytics Janssen Pharmaceuticals (J&J)

Danielle Bradbury
VP Quality Assurance Galera Therapeutics

Prof. Niels Chavannes, MD, PhD
Head of Research, Public Health & Primary Care Leiden University Medical Center

Cari Jacobs Blom
Director Quality & Compliance CR2O

Prof. Sjaak Bloem, PhD
Associate Director Behavioral Science Janssen Pharmaceuticals (J&J)

Allan Bukuya
COO TrialDocs International

Nick van den Bulk
Head Clinical Operations CR2O

Prof. Eric Claassen, PhD
Sequential Biotech Entrepreneur & Angel Investor Multiple ventures
One Response
i like this project nice that i have invet in this project